<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Vascular lesions in the newborn</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Vascular lesions in the newborn</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Vascular lesions in the newborn</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Lucia Z Diaz, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Moise L Levy, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rosamaria Corona, MD, DSc</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 22, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Vascular lesions, including vascular neoplasms and vascular malformations, are common in newborns [<a href="#rid1">1</a>]. Although the majority of these lesions are benign and self-limited conditions, some may be part of complex syndromes or systemic disorders or may be associated with complications.</p><p>Vascular lesions presenting in the newborn will be reviewed here. Other neonatal skin lesions and inherited skin disorders are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5790.html" rel="external">"Vesicular, pustular, and bullous lesions in the newborn and infant"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5788.html" rel="external">"Skin nodules in newborns and infants"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/119230.html" rel="external">"Skin lesions in the newborn and infant"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4847.html" rel="external">"Congenital melanocytic nevi"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3004.html" rel="external">"The genodermatoses: An overview"</a>.)</p><p></p><p class="headingAnchor" id="H1504701453"><span class="h1">CLASSIFICATION OF VASCULAR ANOMALIES</span><span class="headingEndMark"> — </span>The 2018 classification of the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.issva.org%2F&amp;token=AxdOYZDP6%2F9e17f8kv7xV1EvgCsksQntnoA3NW3vpRc%3D&amp;TOPIC_ID=5789" target="_blank">International Society for the Study of Vascular Anomalies</a> divides the vascular anomalies into the following broad categories [<a href="#rid2">2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Vascular tumors, including benign, borderline, and malignant tumors</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Simple malformations, including capillary malformations, lymphatic malformations, venous malformations, and arteriovenous fistula</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Combined vascular malformations, defined as two or more vascular malformations found in a single lesion</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anomalies of major named vessels</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Vascular malformations associated with other anomalies, which include Sturge-Weber syndrome, Klippel-Trenaunay syndrome, macrocephaly-capillary malformation, Proteus syndrome, and CLOVES (congenital lipomatous overgrowth, vascular malformations, epidermal nevi, spinal/skeletal anomalies/scoliosis) syndrome</p><p></p><p class="headingAnchor" id="H2543784424"><span class="h1">VASCULAR TUMORS</span></p><p class="headingAnchor" id="H2615244240"><span class="h2">Infantile hemangiomas</span><span class="headingEndMark"> — </span>Infantile hemangiomas are the most common benign tumors of infancy. The pathophysiology, clinical features, complications, evaluation, and management of infantile hemangiomas are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/5794.html" rel="external">"Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications"</a> and  <a class="medical medical_review" href="/d/html/5793.html" rel="external">"Infantile hemangiomas: Evaluation and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/5792.html" rel="external">"Infantile hemangiomas: Management"</a>.)</p><p class="headingAnchor" id="H1682709091"><span class="h2">Congenital hemangiomas</span><span class="headingEndMark"> — </span>Congenital hemangiomas are rare, benign vascular tumors that are present and fully grown at birth. They present as bossed plaques  (<a class="graphic graphic_picture graphicRef88908" href="/d/graphic/88908.html" rel="external">picture 1</a>) or exophytic masses  (<a class="graphic graphic_picture graphicRef88800" href="/d/graphic/88800.html" rel="external">picture 2</a>) located on the head, neck, or limbs. Based upon their natural history, two major subtypes have been recognized: rapidly involuting congenital hemangiomas (RICH) and noninvoluting congenital hemangiomas (NICH). There is also a partially involuting congenital hemangioma (PICH) that shares overlapping features seen in a RICH and NICH.</p><p>Congenital hemangiomas are reviewed separately. (See  <a class="medical medical_review" href="/d/html/13727.html" rel="external">"Congenital hemangiomas: Rapidly involuting congenital hemangioma (RICH), noninvoluting congenital hemangioma (NICH), and partially involuting congenital hemangioma (PICH)"</a>.)</p><p class="headingAnchor" id="H2188398948"><span class="h2">Tufted angioma and kaposiform hemangioendothelioma</span><span class="headingEndMark"> — </span>Tufted angioma and kaposiform hemangioendothelioma (KHE) are rare vascular tumors that typically present during infancy or early childhood. They may be associated with the Kasabach-Merritt phenomenon, a life-threatening complication characterized by severe thrombocytopenia and coagulopathy.</p><p>Tufted angioma, KHE, and the Kasabach-Merritt phenomenon are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/86314.html" rel="external">"Tufted angioma, kaposiform hemangioendothelioma (KHE), and Kasabach-Merritt phenomenon (KMP)"</a>.)</p><p class="headingAnchor" id="H3476392124"><span class="h2">Pyogenic granuloma</span><span class="headingEndMark"> — </span>Pyogenic granuloma or lobular capillary hemangioma is a benign vascular tumor of the skin or mucous membranes characterized by rapid growth and friable surface  (<a class="graphic graphic_picture graphicRef105762" href="/d/graphic/105762.html" rel="external">picture 3</a>). Although more common in infants older than four months and young children, pyogenic granuloma may occur in the newborn [<a href="#rid3">3,4</a>].</p><p>The pathogenesis, clinical manifestations, diagnosis, and treatment of pyogenic granuloma are discussed separately. (See  <a class="medical medical_review" href="/d/html/13736.html" rel="external">"Pyogenic granuloma (lobular capillary hemangioma)"</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">VASCULAR MALFORMATIONS</span><span class="headingEndMark"> — </span>Vascular malformations are anomalies of vessel morphogenesis. Unlike neoplasms, endothelial turnover is normal. Depending upon the type of involved vessels and flow characteristics, vascular malformation can be divided into low flow (capillary, venous, lymphatic, or combination) and high flow (arterial, arteriovenous).</p><p>Vascular malformations are always present at birth but often are clinically subtle and become more apparent over time as they slowly expand in proportion to the infant's overall growth. In addition, there is progressive ectasia secondary to changes in blood or lymphatic flow, pressure associated with trauma, or hormonal changes such as at puberty. Vascular malformations are in most cases an isolated finding but may occur in the setting of complex inherited and congenital disorders.</p><p class="headingAnchor" id="H2761550389"><span class="h2">Capillary malformations</span><span class="headingEndMark"> — </span>Capillary malformations appear as pink-red macular lesions on the skin or mucosa. They are present at birth and generally persist throughout life, although some variants, such as nevus simplex, may fade and disappear during the first few years of life. Capillary malformations may be an isolated finding or occur in association with a wide range of cutaneous or systemic abnormalities in complex inherited or sporadic disorders. (See <a class="local">'Vascular malformations associated with other anomalies'</a> below and  <a class="medical medical_review" href="/d/html/13726.html" rel="external">"Capillary malformations (port wine birthmarks) and associated syndromes"</a>.)</p><p class="headingAnchor" id="H4"><span class="h3">Nevus simplex (macular stain)</span><span class="headingEndMark"> — </span>Nevus simplex (also called macular stain, salmon patch, stork bite, or angel kiss) presents as single or multiple blanchable, pink-red patches in newborn infants  (<a class="graphic graphic_picture graphicRef70234 graphicRef72513 graphicRef81729" href="/d/graphic/70234.html" rel="external">picture 4A-C</a>). These lesions occur in 40 to 60 percent of infants, most commonly on the eyelid, glabella, and midline of the nape of the neck. Less common sites of involvement include the scalp, nose, lip, and back [<a href="#rid5">5</a>]. Nevus simplex generally fades within one to two years, although lesions on the back of the neck may persist unchanged with little consequence [<a href="#rid6">6</a>].</p><p>Rarely, nevus simplex may be associated with extracutaneous disorders such as spinal dysraphism, Beckwith-Wiedemann syndrome, macrocephaly-capillary malformation syndrome, or other conditions [<a href="#rid5">5</a>]. (See  <a class="medical medical_review" href="/d/html/13555.html" rel="external">"Beckwith-Wiedemann syndrome"</a> and <a class="local">'Cutis marmorata telangiectatica congenita'</a> below.)</p><p>In patients with lumbosacral nevus simplex, imaging studies to evaluate for underlying spinal dysraphism are recommended when another lumbosacral abnormality such as a dermal sinus or pit, lipoma, patch of hypertrichosis, or deviated gluteal cleft is present [<a href="#rid5">5</a>]. It is unclear whether spinal imaging should be routinely performed in patients with isolated lumbosacral nevus simplex as the risk of underlying spinal abnormalities may be low in this group [<a href="#rid7">7-10</a>]. We typically do not image patients in the absence of other lumbosacral abnormalities. (See  <a class="medical medical_review" href="/d/html/14405.html" rel="external">"Closed spinal dysraphism: Pathogenesis and types"</a>.)</p><p class="headingAnchor" id="H5"><span class="h3">Port wine birthmarks</span><span class="headingEndMark"> — </span>Port wine birthmarks or nevus flammeus are low-flow vascular malformations of dermal capillaries and postcapillary venules. They are present at birth in 0.1 to 0.2 percent of newborns as blanchable pink to red patches on skin and/or mucosa and may be located anywhere on the body, typically with a unilateral or segmental distribution that respects the midline  (<a class="graphic graphic_picture graphicRef59124 graphicRef73978 graphicRef54078" href="/d/graphic/59124.html" rel="external">picture 5A-C</a>) [<a href="#rid1">1</a>]. Port wine birthmarks do not regress but grow in proportion to the child's growth and become thicker and darker in color during adulthood. Port wine birthmarks and associated syndromes are discussed separately. (See  <a class="medical medical_review" href="/d/html/13726.html" rel="external">"Capillary malformations (port wine birthmarks) and associated syndromes"</a>.)</p><p class="headingAnchor" id="H2239122757"><span class="h2">Lymphatic malformations</span><span class="headingEndMark"> — </span>Lymphatic malformations (LM) are benign, slow-flow vascular lesions composed of dilated lymphatic channels or cysts lined by endothelial cells with a lymphatic phenotype [<a href="#rid2">2</a>]. They are classified as macrocystic (cystic hygroma), microcystic (lymphangioma circumscriptum), and mixed type.</p><p class="headingAnchor" id="H2284145152"><span class="h3">Macrocystic lymphatic malformation (cystic hygroma)</span><span class="headingEndMark"> — </span>Macrocystic lymphatic malformation, also referred to as cystic hygroma, is composed of collections of large, interconnected lymphatic cysts lined by a thin endothelium. It presents at birth as a large, poorly delimitated, translucent, soft mass covered by normal skin, most commonly located in the cervicofacial region, axilla, or lateral chest wall  (<a class="graphic graphic_picture graphicRef105718" href="/d/graphic/105718.html" rel="external">picture 6</a>). Cystic hygroma can be detected prenatally in the first trimester of pregnancy and, in approximately 50 percent cases, is associated with chromosomal abnormalities, such as Down syndrome, Turner syndrome, and Noonan syndrome. (See  <a class="medical medical_review" href="/d/html/435.html" rel="external">"Enlarged nuchal translucency and cystic hygroma"</a>.)</p><p class="headingAnchor" id="H3317832536"><span class="h3">Microcystic lymphatic malformation (lymphangioma circumscriptum)</span><span class="headingEndMark"> — </span>Lymphangioma circumscriptum is a type of microcystic lymphatic malformation that may be present at birth or appear in the first few years of life. The most frequent localizations are proximal extremities, trunk, axilla, and the oral cavity. Clinically, lymphangioma circumscriptum presents as a cluster of clear, translucent or hemorrhagic vesicles that may intermittently leak lymphatic fluid  (<a class="graphic graphic_picture graphicRef105768" href="/d/graphic/105768.html" rel="external">picture 7</a>). (See  <a class="medical medical_review" href="/d/html/6282.html" rel="external">"Soft tissue lesions of the oral cavity in children", section on 'Lymphangiomas'</a>.)</p><p class="headingAnchor" id="H968554164"><span class="h2">Venous malformations</span><span class="headingEndMark"> — </span>Venous malformations are the most frequent low-flow vascular malformations [<a href="#rid11">11</a>]. They may involve the skin, mucosa, deep soft tissues, and internal organs. They result from inborn errors in the development of the venous network, leading to dilated and dysfunctional veins that are deficient in smooth muscle cells. Although inherited forms exist, more than 90 percent of venous malformations occur sporadically. </p><p>In the newborn, mucocutaneous venous malformations present as bluish, ill-defined, compressible lesions  (<a class="graphic graphic_picture graphicRef105862" href="/d/graphic/105862.html" rel="external">picture 8</a>). A thrill or bruit is absent on auscultation, and, on palpation, the involved skin is not warmer than the adjacent skin. Patients with extensive venous malformations develop a chronic localized intravascular coagulopathy with permanently elevated D-dimer levels that may result in thrombosis or bleeding [<a href="#rid12">12</a>]. </p><p>The pathogenesis, clinical presentation, diagnosis, and management of venous malformations are discussed separately. (See  <a class="medical medical_review" href="/d/html/110155.html" rel="external">"Venous malformations"</a>.)</p><p class="headingAnchor" id="H1680390885"><span class="h2">Arteriovenous malformations</span><span class="headingEndMark"> — </span>Arteriovenous malformations are fast-flow vascular malformations composed of abnormal arteries, veins, and capillaries, with direct arteriovenous communications resulting in arteriovenous shunting [<a href="#rid2">2</a>]. They may occur sporadically or in patients with hereditary hemorrhagic telangiectasia or capillary malformation-arteriovenous malformation.</p><p>In the newborn, arteriovenous malformations present as capillary malformation-like lesions  (<a class="graphic graphic_picture graphicRef83553" href="/d/graphic/83553.html" rel="external">picture 9</a>) or, less frequently, as purple-red swollen lesions  (<a class="graphic graphic_picture graphicRef83576" href="/d/graphic/83576.html" rel="external">picture 10</a>). Lesions are warm on palpation and may have an audible thrill or bruit. (See <a class="local">'Capillary malformation-arteriovenous malformation syndrome'</a> below.)</p><p class="headingAnchor" id="H793097204"><span class="h1">VASCULAR MALFORMATIONS ASSOCIATED WITH OTHER ANOMALIES</span></p><p class="headingAnchor" id="H6"><span class="h2">Sturge-Weber syndrome</span><span class="headingEndMark"> — </span>Sturge-Weber syndrome is a rare congenital, but not hereditary, vascular disorder characterized by a facial capillary malformation involving the V1 +/- V2 dermatome and an associated leptomeningeal vascular malformation  (<a class="graphic graphic_picture graphicRef60560 graphicRef73343" href="/d/graphic/60560.html" rel="external">picture 11A-B</a>). These malformations may be associated with specific ocular (predominantly glaucoma) and neurologic abnormalities, including seizures, hemiparesis, intellectual disability, and behavior problems. Sturge-Weber syndrome is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/6159.html" rel="external">"Sturge-Weber syndrome"</a>.)</p><p class="headingAnchor" id="H7"><span class="h2">Klippel-Trenaunay syndrome</span><span class="headingEndMark"> — </span>Klippel-Trenaunay syndrome (KTS) is a rare congenital disorder characterized by the presence of capillary malformation, venous malformation or varicosities, and limb overgrowth, with or without lymphatic anomalies  (<a class="graphic graphic_picture graphicRef51296" href="/d/graphic/51296.html" rel="external">picture 12</a>) [<a href="#rid2">2</a>]. KTS is considered part of the <em>PIK3CA</em>-related overgrowth spectrum (PROS) [<a href="#rid13">13</a>]. The pathogenesis, clinical manifestations, diagnosis, and management of KTS are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/13730.html" rel="external">"Klippel-Trenaunay syndrome: Clinical manifestations, diagnosis, and management"</a>.)</p><p class="headingAnchor" id="H8"><span class="h2">Cutis marmorata telangiectatica congenita</span><span class="headingEndMark"> — </span>Cutis marmorata telangiectatica congenita (CMTC; also called nevus vascularis reticularis and congenital livedo reticularis) is a vascular anomaly characterized by a generalized or localized reticulated cutaneous vascular network. No sex predominance has consistently been demonstrated [<a href="#rid14">14,15</a>].</p><p>Generalized CMTC can be a feature of Adams-Oliver syndrome (MIM #100300), a rare developmental disorder characterized by aplasia cuts congenita and limb defects. In a review of 78 patients with CMTC, CMTC was generalized in 17 patients (22 percent), and 15 of these (88 percent) met the criteria for the diagnosis of Adams-Oliver syndrome [<a href="#rid16">16</a>]. (See  <a class="medical medical_review" href="/d/html/13725.html" rel="external">"Aplasia cutis congenita", section on 'Associated genetic syndromes or congenital anomalies'</a>.)</p><p>Like cutis marmorata  (<a class="graphic graphic_picture graphicRef50846" href="/d/graphic/50846.html" rel="external">picture 13</a>), it may be accentuated by cold. However, unlike cutis marmorata, the cutaneous abnormalities do not usually resolve with rewarming and exhibit a coarser vasculature that may be associated with skin atrophy and ulceration  (<a class="graphic graphic_picture graphicRef64092 graphicRef74935" href="/d/graphic/64092.html" rel="external">picture 14A-B</a>). (See  <a class="medical medical_review" href="/d/html/119230.html" rel="external">"Skin lesions in the newborn and infant", section on 'Cutis marmorata'</a>.)</p><p>In more than two-thirds of cases, CMTC affects the limbs (especially the legs), which may become discrepant in size and shape in approximately half of the cases [<a href="#rid14">14,17</a>]. The face and trunk are less commonly affected. Lesions are unilateral in 65 percent of cases [<a href="#rid14">14</a>]. They usually fade or resolve spontaneously within two years but rarely may persist unchanged [<a href="#rid15">15,18</a>].</p><p>If limb length discrepancy is noted, standing leg-length radiographs are recommended at the age of 10 years for girls or 12 years for boys; if limb length discrepancy is &gt;2 cm, orthopedic referral may be warranted [<a href="#rid17">17</a>]. Other cutaneous and extracutaneous features associated with CMTC include port wine birthmark, glaucoma (especially with facial involvement), localized aplasia cutis congenita, cleft palate, or other malformations [<a href="#rid15">15,16,19-21</a>].</p><p class="headingAnchor" id="H1731275988"><span class="h2">Capillary malformation-arteriovenous malformation syndrome</span><span class="headingEndMark"> — </span>Capillary malformation-arteriovenous malformation syndrome (CM-AVM, MIM #608354) is an autosomal dominant disorder caused by mutations in the <em>RASA1 </em>gene [<a href="#rid22">22</a>]. CM-AVM presents with multiple small capillary malformations associated with high-flow arteriovenous malformations and arteriovenous fistulas located in the soft tissues, bone, or central nervous system. Red punctate spots surrounded by pale halos, often with associated hypotrichosis, are frequent findings [<a href="#rid23">23</a>]. (See  <a class="medical medical_review" href="/d/html/13726.html" rel="external">"Capillary malformations (port wine birthmarks) and associated syndromes", section on 'Capillary malformation-arteriovenous malformation syndrome'</a>.)</p><p class="headingAnchor" id="H3092011"><span class="h2">Macrocephaly-capillary malformation syndrome</span><span class="headingEndMark"> — </span>Macrocephaly-capillary malformation (M-CM) syndrome, previously named macrocephaly-cutis marmorata telangiectatica congenita (MIM #602501), is a genetic syndrome characterized by an enlarged head circumference and patchy, reticular capillary malformations that sometimes resemble CMTC, but with a finer, livedo-like pattern and no atrophy [<a href="#rid24">24-26</a>]. Other clinical features may include polydactyly/syndactyly, neonatal hypotonia, developmental delay, and structural brain abnormalities [<a href="#rid24">24,27,28</a>]. The vascular lesions often fade during the first few years of life. (See  <a class="medical medical_review" href="/d/html/13726.html" rel="external">"Capillary malformations (port wine birthmarks) and associated syndromes", section on 'Microcephaly-capillary malformation syndrome'</a>.)</p><p class="headingAnchor" id="H9"><span class="h2">Phakomatosis pigmentovascularis</span><span class="headingEndMark"> — </span>Phakomatosis pigmentovascularis (PPV) is a rare syndrome characterized by the association of a capillary malformation with dermal melanocytosis (Mongolian spot, nevus of Ota), nevus spilus, or epidermal nevus. The etiology is thought to be a developmental abnormality of the vasomotor nerves and melanocytes, both derived from neural crest [<a href="#rid29">29</a>]. All ethnic groups may be affected [<a href="#rid30">30</a>]. Five types of PPV have been identified  (<a class="graphic graphic_table graphicRef105804" href="/d/graphic/105804.html" rel="external">table 1</a>), the most common being type II or phakomatosis cesioflammea (port wine birthmark plus blue spots such as nevus of Ota or Mongolian spots), formerly known as PPV types IIa and IIb [<a href="#rid31">31,32</a>]. (See  <a class="medical medical_review" href="/d/html/5560.html" rel="external">"Benign pigmented skin lesions other than melanocytic nevi (moles)", section on 'Dermal melanocytoses'</a> and  <a class="medical medical_review" href="/d/html/13728.html" rel="external">"Epidermal nevus and epidermal nevus syndrome"</a>.)</p><p>Capillary malformation is present in most PPV types and is usually extensive. In one series of 15 PPV cases, all had facial capillary malformations, and 80 percent had additional capillary malformations in other areas [<a href="#rid31">31</a>]. As many as half of patients have other associated cutaneous lesions, most commonly nevus anemicus and café-au-lait spots [<a href="#rid31">31</a>].</p><p>It has been estimated that approximately 50 percent of patients have systemic involvement; neurologic, ocular, and skeletal abnormalities occur most frequently [<a href="#rid31">31,33</a>]. Neurologic abnormalities usually present in the first few months of life and include psychomotor retardation, seizures, intracranial calcifications, or cerebral atrophy [<a href="#rid34">34</a>]. Ocular involvement, such as blue-gray scleral discoloration, is also common. Management and outcome depend upon the presence of other associated conditions.</p><p class="headingAnchor" id="H3826604193"><span class="h2">Proteus syndrome</span><span class="headingEndMark"> — </span>Proteus syndrome is an extremely rare disorder caused by somatic activating mutations in the <em>AKT1</em> oncogene and characterized by asymmetric and disproportionate progressive overgrowth of body parts  (<a class="graphic graphic_picture graphicRef83559" href="/d/graphic/83559.html" rel="external">picture 15</a>) [<a href="#rid35">35</a>]. Cutaneous findings are present in approximately 40 percent of neonates and include capillary, lymphatic, or venous malformations; epidermal nevi; connective tissue nevi; lipomas; and café au lait macules. The vascular malformations are usually extensive, covering a large portion of the body, and may be associated with visceral vascular malformations. (See  <a class="medical medical_review" href="/d/html/16543.html" rel="external">"PTEN hamartoma tumor syndromes, including Cowden syndrome", section on 'Proteus-like syndrome'</a>.)</p><p class="headingAnchor" id="H289635786"><span class="h2">CLOVES syndrome</span><span class="headingEndMark"> — </span>CLOVES (congenital lipomatous overgrowth, vascular malformations, epidermal nevi, spinal/skeletal anomalies/scoliosis) syndrome (MIM #6129180) is a rare disorder caused by somatic mosaicism for postzygotic activating mutations in the <em>PIK3CA</em> gene on chromosome 3q26 [<a href="#rid36">36</a>]. The term <em>PIK3CA</em>-related overgrowth spectrum (PROS) is used to encompass multiple clinical syndromes with segmental tissue and/or vascular overgrowth associated with somatic <em>PIK3CA</em> mutations, including CLOVES, M-CM syndrome, fibroadipose overgrowth, and KTS [<a href="#rid37">37,38</a>]. (See  <a class="medical medical_review" href="/d/html/13730.html" rel="external">"Klippel-Trenaunay syndrome: Clinical manifestations, diagnosis, and management", section on 'CLOVES syndrome'</a>.)</p><p>Patients with CLOVES syndrome present at birth with truncal, lipomatous masses of various sizes infiltrating the adjacent tissues; combined vascular malformations, including capillary, lymphatic, venous (phlebectasias), and arteriovenous malformations (geographic stains); hand and feet deformities (macrodactyly, "sandal gap" toe deformity); and scoliosis [<a href="#rid39">39</a>]. In contrast with Proteus syndrome, the overgrowth present at birth is nonprogressive.</p><p>Patients with CLOVES syndrome have an increased risk of developing Wilms tumor (WT). In a review of 122 patients with CLOVES syndrome, 4 (3.3 percent) developed WT by the age of two years [<a href="#rid40">40</a>]. This incidence was significantly higher than that observed in the general population (1 in 10,000 births).</p><p class="headingAnchor" id="H1761031572"><span class="h2">Maffucci syndrome</span><span class="headingEndMark"> — </span>Maffucci syndrome is a rare developmental disorder characterized by venous vascular malformations that may be present at birth and multiple enchondromas in early childhood [<a href="#rid41">41</a>]. Maffucci syndrome is caused by somatic mutations in the isocitrate dehydrogenase genes <em>IDH1</em> and <em>IDH2</em> and is associated with a substantial risk of malignant transformation of enchondroma to chondrosarcoma later in life [<a href="#rid42">42</a>]. (See  <a class="medical medical_review" href="/d/html/110155.html" rel="external">"Venous malformations", section on 'Maffucci syndrome'</a>.)</p><p class="headingAnchor" id="H2100903884"><span class="h1">OTHER VASCULAR LESIONS</span></p><p class="headingAnchor" id="H3106833733"><span class="h2">Nevus anemicus</span><span class="headingEndMark"> — </span>Nevus anemicus is a vascular anomaly presenting at birth as a pale area of the skin of various size and shape, usually located on the trunk  (<a class="graphic graphic_picture graphicRef105713" href="/d/graphic/105713.html" rel="external">picture 16</a>). It is caused by a localized, increased vascular sensitivity to endogenous catecholamines resulting in persistent vasoconstriction. On diascopy, which consists in applying pressure to the lesion and adjacent normal skin with a glass slide, nevus anemicus is indistinguishable from the surrounding skin.</p><p>Nevus anemicus is in most cases an isolated finding but may occur in association with several genetic syndromes, including phakomatosis pigmentovascularis, neurofibromatosis, and tuberous sclerosis complex [<a href="#rid43">43-46</a>]. (See <a class="local">'Phakomatosis pigmentovascularis'</a> above and  <a class="medical medical_review" href="/d/html/2939.html" rel="external">"Neurofibromatosis type 1 (NF1): Pathogenesis, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/6175.html" rel="external">"Tuberous sclerosis complex: Clinical features"</a>.)</p><p class="headingAnchor" id="H3003071995"><span class="h2">STING-associated vasculopathy with onset in infancy</span><span class="headingEndMark"> — </span>Stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy (SAVI; MIM #615934) is an autoinflammatory disease caused by gain-of-function heterozygous mutations in the gene encoding STING (<em>TMEM173</em>, transmembrane protein 173, on chromosome 5q31.2), resulting in the upregulation of type 1 interferon signaling and elevated levels of interferon-induced cytokines in the peripheral blood [<a href="#rid47">47</a>]. Patients presents in early infancy with a hyperinflammatory state, severe cutaneous vasculopathy, and interstitial lung disease. (See  <a class="medical medical_review" href="/d/html/116307.html" rel="external">"Autoinflammatory diseases mediated by interferon production and signaling (interferonopathies)", section on 'STING-associated vasculopathy with onset in infancy (SAVI)'</a>.)</p><p>Cutaneous lesions include purple-red telangiectatic plaques, pustules, and blisters involving the cheeks, helix and lobule of the ears, tip of the nose, and dorsal side of the hands, fingers, and toes [<a href="#rid47">47,48</a>]. These lesions worsen with cold weather and may ulcerate, leading to tissue loss and severe scarring. Skin biopsy reveals microthrombotic vascular changes and a dense pericapillary lymphocytic and neutrophilic infiltrate with nuclear dust.</p><p class="headingAnchor" id="H23409084"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Classification</strong> – Vascular lesions are common in newborns. They are classified into vascular tumors, simple malformations, combined malformations, anomalies of major named vessels, and malformations associated with other anomalies. (See <a class="local">'Classification of vascular anomalies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vascular tumors</strong> – Infantile hemangiomas are the most common benign tumors of infancy. Rare vascular tumors of the newborn include congenital hemangioma, tufted angioma and kaposiform hemangioendothelioma, and pyogenic granuloma. These tumors are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/5794.html" rel="external">"Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications"</a> and  <a class="medical medical_review" href="/d/html/13727.html" rel="external">"Congenital hemangiomas: Rapidly involuting congenital hemangioma (RICH), noninvoluting congenital hemangioma (NICH), and partially involuting congenital hemangioma (PICH)"</a> and  <a class="medical medical_review" href="/d/html/86314.html" rel="external">"Tufted angioma, kaposiform hemangioendothelioma (KHE), and Kasabach-Merritt phenomenon (KMP)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vascular malformations</strong> – Vascular malformations are anomalies of vessel morphogenesis. Depending upon the type of involved vessels and flow characteristics, vascular malformation can be divided into low flow (capillary, venous, lymphatic, or combination) and high flow (arterial, arteriovenous). They may occur in isolation or in the setting of complex inherited and congenital disorders. (See <a class="local">'Vascular malformations'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Capillary malformations appear as pink-red macular lesions on the skin or mucosa  (<a class="graphic graphic_picture graphicRef83601" href="/d/graphic/83601.html" rel="external">picture 17</a>). They are present at birth and generally persist throughout life, although some variants, such as nevus simplex, may fade and disappear during the first few years of life. Capillary malformations may be an isolated finding or occur in association with other cutaneous or systemic abnormalities in complex inherited or sporadic disorders. (See <a class="local">'Capillary malformations'</a> above and  <a class="medical medical_review" href="/d/html/13726.html" rel="external">"Capillary malformations (port wine birthmarks) and associated syndromes"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Lymphatic malformations (LM) are benign, slow-flow vascular lesions composed of dilated lymphatic channels or cysts lined by endothelial cells with a lymphatic phenotype. They are classified as macrocystic (cystic hygroma)  (<a class="graphic graphic_picture graphicRef105718" href="/d/graphic/105718.html" rel="external">picture 6</a>), microcystic (lymphangioma circumscriptum)  (<a class="graphic graphic_picture graphicRef105768" href="/d/graphic/105768.html" rel="external">picture 7</a>), and mixed type. (See <a class="local">'Lymphatic malformations'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Venous malformations are low-flow vascular malformations presenting as bluish, ill-defined, compressible nodules or masses  (<a class="graphic graphic_picture graphicRef105862" href="/d/graphic/105862.html" rel="external">picture 8</a>). They may involve the skin, mucosa, deep soft tissues, and internal organs. Large lesions may develop a chronic localized intravascular coagulopathy that results in thrombosis or bleeding. Venous malformations are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/110155.html" rel="external">"Venous malformations"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Arteriovenous malformations are composed of abnormal arteries, veins, and capillaries, with direct arteriovenous communications resulting in arteriovenous shunting. The may present clinically as capillary malformation-like lesions  (<a class="graphic graphic_picture graphicRef83553" href="/d/graphic/83553.html" rel="external">picture 9</a>) or purple-red, warm, painful lesions that may become ulcerated and bleed  (<a class="graphic graphic_picture graphicRef83576" href="/d/graphic/83576.html" rel="external">picture 10</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vascular malformations associated with other anomalies</strong> – Vascular malformations associated with other anomalies include Sturge-Weber syndrome, Klippel-Trenaunay syndrome, macrocephaly-capillary malformation, Proteus syndrome, and CLOVES (congenital lipomatous overgrowth, vascular malformations, epidermal nevi, spinal/skeletal anomalies/scoliosis) syndrome. (See <a class="local">'Vascular malformations associated with other anomalies'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nevus anemicus</strong> – Nevus anemicus is a vascular anomaly presenting at birth as a pale area of the skin of various size and shape, usually located on the trunk  (<a class="graphic graphic_picture graphicRef105713" href="/d/graphic/105713.html" rel="external">picture 16</a>). It is caused by a localized increased vascular sensitivity to endogenous catecholamines resulting in persistent vasoconstriction. Nevus anemicus is in most cases an isolated finding but may occur in association with phakomatosis pigmentovascularis, neurofibromatosis, or tuberous sclerosis complex. (See <a class="local">'Nevus anemicus'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>STING-associated vasculopathy with onset in infancy</strong> – STING-associated vasculopathy with onset in infancy (SAVI) is an autoinflammatory disease presenting in early infancy with a hyperinflammatory state, severe cutaneous vasculopathy, and interstitial lung disease. Vascular lesions include telangiectatic plaques, pustules, and blisters involving the cheeks, ears, tip of the nose, and dorsal side of the hands, fingers, and toes. (See <a class="local">'STING-associated vasculopathy with onset in infancy'</a> above.) </p><p></p><p class="headingAnchor" id="H26150922"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Josie A Pielop, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Kanada KN, Merin MR, Munden A, Friedlander SF. A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature. J Pediatr 2012; 161:240.</a></li><li><a class="nounderline abstract_t">Martinez-Lopez A, Salvador-Rodriguez L, Montero-Vilchez T, et al. Vascular malformations syndromes: an update. Curr Opin Pediatr 2019.</a></li><li><a class="nounderline abstract_t">Mallet S, Rebelle C, Ligi I, et al. Congenital and disseminated pyogenic granuloma-like vascular lesions. Acta Derm Venereol 2015; 95:860.</a></li><li><a class="nounderline abstract_t">Browning JC, Eldin KW, Kozakewich HP, et al. Congenital disseminated pyogenic granuloma. Pediatr Dermatol 2009; 26:323.</a></li><li><a class="nounderline abstract_t">Juern AM, Glick ZR, Drolet BA, Frieden IJ. Nevus simplex: a reconsideration of nomenclature, sites of involvement, and disease associations. J Am Acad Dermatol 2010; 63:805.</a></li><li><a class="nounderline abstract_t">Cohen BA. Hemangiomas in infancy and childhood. Pediatr Ann 1987; 16:17.</a></li><li><a class="nounderline abstract_t">Metzker A, Shamir R. Butterfly-shaped mark: a variant form of nevus flammeus simplex. Pediatrics 1990; 85:1069.</a></li><li><a class="nounderline abstract_t">Oakes WJ. Butterfly-shaped mark. Pediatrics 1991; 87:956.</a></li><li><a class="nounderline abstract_t">Patrizi A, Neri I, Orlandi C, Marini R. Sacral medial telangiectatic vascular nevus: a study of 43 children. Dermatology 1996; 192:301.</a></li><li><a class="nounderline abstract_t">Ben-Amitai D, Davidson S, Schwartz M, et al. Sacral nevus flammeus simplex: the role of imaging. Pediatr Dermatol 2000; 17:469.</a></li><li><a class="nounderline abstract_t">Dompmartin A, Vikkula M, Boon LM. Venous malformation: update on aetiopathogenesis, diagnosis and management. Phlebology 2010; 25:224.</a></li><li><a class="nounderline abstract_t">Dompmartin A, Ballieux F, Thibon P, et al. Elevated D-dimer level in the differential diagnosis of venous malformations. Arch Dermatol 2009; 145:1239.</a></li><li><a class="nounderline abstract_t">Luks VL, Kamitaki N, Vivero MP, et al. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr 2015; 166:1048.</a></li><li><a class="nounderline abstract_t">Amitai DB, Fichman S, Merlob P, et al. Cutis marmorata telangiectatica congenita: clinical findings in 85 patients. Pediatr Dermatol 2000; 17:100.</a></li><li><a class="nounderline abstract_t">Kienast AK, Hoeger PH. Cutis marmorata telangiectatica congenita: a prospective study of 27 cases and review of the literature with proposal of diagnostic criteria. Clin Exp Dermatol 2009; 34:319.</a></li><li><a class="nounderline abstract_t">Downey C, Metry D, Garzon MC, et al. Cutis marmorata telangiectatica congenita: Incidence of extracutaneous manifestations and a proposed clinical definition. Pediatr Dermatol 2023; 40:820.</a></li><li><a class="nounderline abstract_t">Memarzadeh A, Pengas I, Syed S, Eastwood DM. Limb length discrepancy in cutis marmorata telangiectatica congenita: an audit of assessment and management in a multidisciplinary setting. Br J Dermatol 2014; 170:681.</a></li><li><a class="nounderline abstract_t">Dohil MA, Baugh WP, Eichenfield LF. Vascular and pigmented birthmarks. Pediatr Clin North Am 2000; 47:783.</a></li><li><a class="nounderline abstract_t">Picascia DD, Esterly NB. Cutis marmorata telangiectatica congenita: report of 22 cases. J Am Acad Dermatol 1989; 20:1098.</a></li><li><a class="nounderline abstract_t">Pehr K, Moroz B. Cutis marmorata telangiectatica congenita: long-term follow-up, review of the literature, and report of a case in conjunction with congenital hypothyroidism. Pediatr Dermatol 1993; 10:6.</a></li><li><a class="nounderline abstract_t">Devillers AC, de Waard-van der Spek FB, Oranje AP. Cutis marmorata telangiectatica congenita: clinical features in 35 cases. Arch Dermatol 1999; 135:34.</a></li><li><a class="nounderline abstract_t">Eerola I, Boon LM, Mulliken JB, et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 2003; 73:1240.</a></li><li><a class="nounderline abstract_t">Martín-Santiago A, Knöpfel N, del Pozo J, et al. Hypotrichosis associated with capillary malformation-arteriovenous malformation syndrome. Br J Dermatol 2015; 172:450.</a></li><li><a class="nounderline abstract_t">Martínez-Glez V, Romanelli V, Mori MA, et al. Macrocephaly-capillary malformation: Analysis of 13 patients and review of the diagnostic criteria. Am J Med Genet A 2010; 152A:3101.</a></li><li><a class="nounderline abstract_t">Wright DR, Frieden IJ, Orlow SJ, et al. The misnomer "macrocephaly-cutis marmorata telangiectatica congenita syndrome": report of 12 new cases and support for revising the name to macrocephaly-capillary malformations. Arch Dermatol 2009; 145:287.</a></li><li><a class="nounderline abstract_t">Toriello HV, Mulliken JB. Accurately renaming macrocephaly-cutis marmorata telangiectatica congenita (M-CMTC) as macrocephaly-capillary malformation (M-CM). Am J Med Genet A 2007; 143A:3009.</a></li><li><a class="nounderline abstract_t">Katugampola R, Moss C, Mills C. Macrocephaly-cutis marmorata telangiectatica congenita: A case report and review of salient features. J Am Acad Dermatol 2008; 58:697.</a></li><li><a class="nounderline abstract_t">Garavelli L, Leask K, Zanacca C, et al. MRI and neurological findings in macrocephaly-cutis marmorata telangiectatica congenita syndrome: report of ten cases and review of the literature. Genet Couns 2005; 16:117.</a></li><li><a class="nounderline abstract_t">Requena L, Sangueza OP. Cutaneous vascular anomalies. Part I. Hamartomas, malformations, and dilation of preexisting vessels. J Am Acad Dermatol 1997; 37:523.</a></li><li><a class="nounderline abstract_t">Vidaurri-de la Cruz H, Tamayo-Sánchez L, Durán-McKinster C, et al. Phakomatosis pigmentovascularis II A and II B: clinical findings in 24 patients. J Dermatol 2003; 30:381.</a></li><li><a class="nounderline abstract_t">Fernández-Guarino M, Boixeda P, de Las Heras E, et al. Phakomatosis pigmentovascularis: Clinical findings in 15 patients and review of the literature. J Am Acad Dermatol 2008; 58:88.</a></li><li><a class="nounderline abstract_t">Happle R. Phacomatosis pigmentovascularis revisited and reclassified. Arch Dermatol 2005; 141:385.</a></li><li><a class="nounderline abstract_t">Huang C, Lee P. Phakomatosis pigmentovascularis IIb with renal anomaly. Clin Exp Dermatol 2000; 25:51.</a></li><li><a class="nounderline abstract_t">Van Gysel D, Oranje AP, Stroink H, Simonsz HJ. Phakomatosis pigmentovascularis. Pediatr Dermatol 1996; 13:33.</a></li><li><a class="nounderline abstract_t">Turner JT, Cohen MM Jr, Biesecker LG. Reassessment of the Proteus syndrome literature: application of diagnostic criteria to published cases. Am J Med Genet A 2004; 130A:111.</a></li><li><a class="nounderline abstract_t">Kurek KC, Luks VL, Ayturk UM, et al. Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet 2012; 90:1108.</a></li><li><a class="nounderline abstract_t">Keppler-Noreuil KM, Rios JJ, Parker VE, et al. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A 2015; 167A:287.</a></li><li><a class="nounderline abstract_t">Vahidnezhad H, Youssefian L, Uitto J. Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS). Exp Dermatol 2016; 25:17.</a></li><li><a class="nounderline abstract_t">Alomari AI. Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: a descriptive study of 18 cases of CLOVES syndrome. Clin Dysmorphol 2009; 18:1.</a></li><li><a class="nounderline abstract_t">Peterman CM, Fevurly RD, Alomari AI, et al. Sonographic screening for Wilms tumor in children with CLOVES syndrome. Pediatr Blood Cancer 2017; 64.</a></li><li><a class="nounderline abstract_t">Pansuriya TC, Kroon HM, Bovée JV. Enchondromatosis: insights on the different subtypes. Int J Clin Exp Pathol 2010; 3:557.</a></li><li><a class="nounderline abstract_t">Amary MF, Damato S, Halai D, et al. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet 2011; 43:1262.</a></li><li><a class="nounderline abstract_t">Sachs C, Lipsker D. Nevus Anemicus and Bier Spots in Tuberous Sclerosis Complex. JAMA Dermatol 2016; 152:217.</a></li><li><a class="nounderline abstract_t">Hernández-Martín A, García-Martínez FJ, Duat A, et al. Nevus anemicus: a distinctive cutaneous finding in neurofibromatosis type 1. Pediatr Dermatol 2015; 32:342.</a></li><li><a class="nounderline abstract_t">Marque M, Roubertie A, Jaussent A, et al. Nevus anemicus in neurofibromatosis type 1: a potential new diagnostic criterion. J Am Acad Dermatol 2013; 69:768.</a></li><li><a class="nounderline abstract_t">Vaassen P, Rosenbaum T. Nevus Anemicus As an Additional Diagnostic Marker of Neurofibromatosis Type 1 in Childhood. Neuropediatrics 2016; 47:190.</a></li><li><a class="nounderline abstract_t">Liu Y, Jesus AA, Marrero B, et al. Activated STING in a vascular and pulmonary syndrome. N Engl J Med 2014; 371:507.</a></li><li><a class="nounderline abstract_t">Munoz J, Rodière M, Jeremiah N, et al. Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Mimic of Childhood Granulomatosis With Polyangiitis. JAMA Dermatol 2015; 151:872.</a></li></ol></div><div id="topicVersionRevision">Topic 5789 Version 28.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22497908" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31361678" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Vascular malformations syndromes: an update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25720992" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Congenital and disseminated pyogenic granuloma-like vascular lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19706097" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Congenital disseminated pyogenic granuloma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20728246" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Nevus simplex: a reconsideration of nomenclature, sites of involvement, and disease associations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3562091" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Hemangiomas in infancy and childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2101578" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Butterfly-shaped mark: a variant form of nevus flammeus simplex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2034512" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Butterfly-shaped mark.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8864361" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Sacral medial telangiectatic vascular nevus: a study of 43 children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11123782" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Sacral nevus flammeus simplex: the role of imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20870869" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Venous malformation: update on aetiopathogenesis, diagnosis and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19917952" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Elevated D-dimer level in the differential diagnosis of venous malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25681199" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10792796" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Cutis marmorata telangiectatica congenita: clinical findings in 85 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19196300" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Cutis marmorata telangiectatica congenita: a prospective study of 27 cases and review of the literature with proposal of diagnostic criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37442634" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Cutis marmorata telangiectatica congenita: Incidence of extracutaneous manifestations and a proposed clinical definition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24641785" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Limb length discrepancy in cutis marmorata telangiectatica congenita: an audit of assessment and management in a multidisciplinary setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10943257" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Vascular and pigmented birthmarks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2666459" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Cutis marmorata telangiectatica congenita: report of 22 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8493172" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Cutis marmorata telangiectatica congenita: long-term follow-up, review of the literature, and report of a case in conjunction with congenital hypothyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9923778" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Cutis marmorata telangiectatica congenita: clinical features in 35 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14639529" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25059281" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Hypotrichosis associated with capillary malformation-arteriovenous malformation syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21077203" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Macrocephaly-capillary malformation: Analysis of 13 patients and review of the diagnostic criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19289759" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The misnomer "macrocephaly-cutis marmorata telangiectatica congenita syndrome": report of 12 new cases and support for revising the name to macrocephaly-capillary malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17963258" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Accurately renaming macrocephaly-cutis marmorata telangiectatica congenita (M-CMTC) as macrocephaly-capillary malformation (M-CM).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18342719" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Macrocephaly-cutis marmorata telangiectatica congenita: A case report and review of salient features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16080291" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : MRI and neurological findings in macrocephaly-cutis marmorata telangiectatica congenita syndrome: report of ten cases and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9344191" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Cutaneous vascular anomalies. Part I. Hamartomas, malformations, and dilation of preexisting vessels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12773803" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Phakomatosis pigmentovascularis II A and II B: clinical findings in 24 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18045734" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Phakomatosis pigmentovascularis: Clinical findings in 15 patients and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15781681" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Phacomatosis pigmentovascularis revisited and reclassified.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10671974" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Phakomatosis pigmentovascularis IIb with renal anomaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8919522" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Phakomatosis pigmentovascularis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15372514" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Reassessment of the Proteus syndrome literature: application of diagnostic criteria to published cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22658544" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25557259" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26268729" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19011570" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: a descriptive study of 18 cases of CLOVES syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28627003" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Sonographic screening for Wilms tumor in children with CLOVES syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20661403" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Enchondromatosis: insights on the different subtypes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22057236" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26580703" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Nevus Anemicus and Bier Spots in Tuberous Sclerosis Complex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25690591" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Nevus anemicus: a distinctive cutaneous finding in neurofibromatosis type 1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23972508" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Nevus anemicus in neurofibromatosis type 1: a potential new diagnostic criterion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27019377" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Nevus Anemicus As an Additional Diagnostic Marker of Neurofibromatosis Type 1 in Childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25029335" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Activated STING in a vascular and pulmonary syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25992765" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Mimic of Childhood Granulomatosis With Polyangiitis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
